Related Experiment Video

Updated: Aug 1, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

A A Russo1, L Tong, J O Lee

  • 1Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Nature
|September 29, 1998
PubMed

Insights

Cyclin-dependent kinases 4 and 6 (Cdk4/6) control cell cycle G1 phase. Their inhibitor, p16INK4a, prevents cyclin binding and ATP interaction, inhibiting cell proliferation and tumor formation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinases 4 and 6 (Cdk4/6) regulate the G1 phase of the cell cycle.
  • The p16INK4a tumor suppressor acts as a crucial inhibitor of Cdk4/6.
  • Dysregulation of Cdk4/6 and p16INK4a is implicated in tumorigenesis.

Purpose of the Study:

  • To elucidate the structural mechanisms by which INK4 inhibitors bind to Cdk4/6.
  • To understand how INK4 inhibitors prevent cyclin binding and ATP interaction.
  • To explore the role of Cdk4/6-INK4a interactions in tumor suppression.

Main Methods:

  • X-ray crystallography of Cdk6 bound to p16INK4a and p19INK4d.
  • Structural analysis of inhibitor binding sites and conformational changes.
  • Mapping of tumor-derived mutations to protein interfaces.

Main Results:

  • INK4 inhibitors bind adjacent to the ATP-binding site, not at the cyclin-binding site.
  • Inhibitor binding induces structural changes that indirectly block cyclin association.
  • INK4 inhibitors distort the catalytic cleft, hindering ATP binding and inhibiting preformed Cdk4/6-cyclin D complexes.
  • Tumor mutations in p16INK4a and Cdk4 affect critical interface contacts.

Conclusions:

  • The structural basis for Cdk4/6 inhibition by INK4 proteins involves indirect mechanisms affecting cyclin and ATP binding.
  • p16INK4a's tumor suppressor function is intrinsically linked to its ability to bind and inhibit Cdk4/6.
  • Understanding these interactions provides insight into cell cycle control and cancer development.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...